Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of a lyophilized herpes zoster mRNA vaccine in adults aged 40 years and older
CTR20262350Phase 3Active
- Sponsor
- Abogen Bioscience
- Start
- Jun 2026
- Countries
- 1
01
Overview
A Phase 3 trial of lyophilized herpes zoster mRNA vaccine in herpes zoster (HZ), sponsored by Abogen Bioscience. Started Jun 2026; status: active.
02
Drugs
lyophilized herpes zoster mRNA vaccine
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on CTR20262350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262350.